Vitamin E attenuates homocysteine and cholesterol induced damage in rat aorta

Cardiovascular Pathology

Volumn 22, Issue 6, 2013, Pages 465-472

  Kirac, Deniz ^a   Negis, Yesim ^a   Ozer, Nesrin Kartal ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

Aorta; Atherosclerosis; Cholesterol; Homocysteine; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL; COLLAGEN; ELASTIN; HOMOCYSTEINE; METHIONINE;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; AORTA DISEASE; AORTA MEDIA; AORTIC DEGENERATION; ARTICLE; CELL DEGENERATION; CHOLESTEROL BLOOD LEVEL; COLLAGEN SYNTHESIS; COLORIMETRY; CONTROLLED STUDY; DIET SUPPLEMENTATION; EXTRACELLULAR MATRIX; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VITAMIN BLOOD LEVEL;

AORTA; ATHEROSCLEROSIS; CHOLESTEROL; HOMOCYSTEINE; VITAMIN E;

ANIMALS; AORTA; AORTIC DISEASES; ATHEROSCLEROSIS; CHOLESTEROL, DIETARY; COLLAGEN; CYTOPROTECTION; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; ELASTIC TISSUE; HOMOCYSTEINE; MALE; METHIONINE; RATS; RATS, WISTAR; TIME FACTORS; VITAMIN E; VITAMIN E DEFICIENCY;

EID: 84893711497     PISSN: 10548807     EISSN: 18791336     Source Type: Journal    
DOI: 10.1016/j.carpath.2013.03.007     Document Type: Article

References (66)

1. McCully KS. Homocysteine and vascular disease. Nat Med 1996;2:386-9.
2. Williams KT, Schalinske KL. Homocysteine metabolism and its relation to health and disease. Biofactors 2010;36:19-24.
3. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991;324:1149-55.
4. Austin RC, Lentz SR, Werstuck GH. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ 2004;11(Suppl 1):S56-64.
5. Welch GN, Upchurch GR, Loscalzo J. Homocysteine, oxidative stress, and vascular disease. Hosp Pract (Minneap) 1997;32:81-82, 85, 88-92.
6. Tsai JC, Perrella MA, Yoshizumi M, Hsieh CM, Haber E, Schlegel R, et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci U S A 1994;91:6369-73.
7. Matthias D, Becker CH, Riezler R, Kindling PH. Homocysteine induced arteriosclerosis-like alterations of the aorta in normotensive and hypertensive rats following application of high doses of methionine. Atherosclerosis 1996;122:201-16.
8. Asada Y, Hayashi T, Tanimura N, Kisanuki A, Sumiyoshi A. Replication of endothelial cells and smooth muscle cells induced in vivo by hypercholesterolaemia and materials released from platelet-rich white thrombus. J Pathol 1992;166:69-75.
9. Zulli A, Buxton BF, Doolan L, Liu JJ. Augmented effects of methionine and cholesterol in decreasing the elastic lamina while thickening the aortic wall in the rat aorta. Clin Sci (Lond) 1998;95:589-93.
10. Kartal Ozer N, Negis Y, Aytan N. Molecular mechanisms of cholesterol or homocysteine effect in the development of atherosclerosis: role of vitamin E. Biofactors 2003;19:63-70.
11. Dutta A, Dutta SK. Vitamin E and its role in the prevention of atherosclerosis and carcinogenesis: a review. J Am Coll Nutr 2003;22:258-68.
12. Azzi A, Gysin R, Kempna P, Munteanu A, Negis Y, Villacorta L, et al. Vitamin E mediates cell signaling and regulation of gene expression. Ann N Y Acad Sci 2004;1031:86-95.
13. Sirikci O, Ozer NK, Azzi A. Dietary cholesterol-induced changes of protein kinase C and the effect of vitamin E in rabbit aortic smooth muscle cells. Atherosclerosis 1996;126:253-63.
14. Ozer NK, Negis Y, Aytan N, Villacorta L, Ricciarelli R, Zingg JM, et al. Vitamin E inhibits CD36 scavenger receptor expression in hypercholesterolemic rabbits. Atherosclerosis 2006;184:15-20.
15. Ozer NK, Sirikci O, Taha S, San T, Moser U, Azzi A. Effect of vitamin E and probucol on dietary cholesterol-induced atherosclerosis in rabbits. Free Radic Biol Med 1998;24:226-33.
16. Nierenberg DW, Nann SL. A method for determining concentrations of retinol, tocopherol, and five carotenoids in human plasma and tissue samples. Am J Clin Nutr 1992;56:417-26.
17. Luna L. Gomori's one step trichrome method. Manual of histologic staining methods of the Armed Forces Institute of Pathology. 3th ed. New York: McGrawhill book company; 1968. p. 93-4.
18. Bancroft JD. A. S. Verhoeffs method for elastic fibers. Theory and practice of histological techniques. 2nd ed. Great Britain: William Clowes Limited; 1982. p. 139.
19. Edwards CA, O'Brien WD. Modified assay for determination of hydroxyproline in a tissue hydrolyzate. Clin Chim Acta 1980;104:161-7.
20. Ueland PM, Refsum H, Beresford SA, Vollset SE. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr 2000;72:324-32.
21. Thambyrajah J, Townend JN. Homocysteine and atherothrombosis-mechanisms for injury. Eur Heart J 2000;21:967-74.
22. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;337:230-6.
23. Verhoef P, Kok FJ, Kruyssen DA, Schouten EG, Witteman JC, Grobbee DE, et al. Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1997;17:989-95.
24. Durand P, Prost M, Loreau N, Lussier-Cacan S, Blache D. Impaired homocysteine metabolism and atherothrombotic disease. Lab Invest 2001;81:645-72.
25. Majors A, Ehrhart LA, Pezacka EH. Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells. Arterioscler Thromb Vasc Biol 1997;17:2074-81.
26. Dudman NP, Hicks C, Wang J, Wilcken DE. Human arterial endothelial cell detachment in vitro: its promotion by homocysteine and cysteine. Atherosclerosis 1991;91:77-83.
27. Outinen PA, Sood SK, Pfeifer SI, Pamidi S, Podor TJ, Li J, et al. Homocysteineinduced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells. Blood 1999;94:959-67.
28. Lentz SR, Sobey CG, Piegors DJ, Bhopatkar MY, Faraci FM, Malinow MR, et al. Vascular dysfunction in monkeys with diet-induced hyperhomocyst (e) inemia. J Clin Invest 1996;98:24-9.
29. Eberhardt RT, Forgione MA, Cap A, Leopold JA, Rudd MA, Trolliet M, et al. Endothelial dysfunction in a murine model of mild hyperhomocyst (e) inemia. J Clin Invest 2000;106:483-91.
30. Bellamy MF, McDowell IF, Ramsey MW, Brownlee M, Bones C, Newcombe RG, et al. Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults. Circulation 1998;98:1848-52.
31. Constans J, Blann AD, Resplandy F, Parrot F, Seigneur M, Renard M, et al. Endothelial dysfunction during acute methionine load in hyperhomocysteinaemic patients. Atherosclerosis 1999;147:411-3.
32. Ross R. The pathogenesis of atherosclerosis-an update. N Engl J Med 1986;314:488-500.
33. Dalton ML, Gadson PF, Wrenn RW, Rosenquist TH. Homocysteine signal cascade: production of phospholipids, activation of protein kinase C, and the induction of cfos and c-myb in smooth muscle cells. FASEB J 1997;11:703-11.
34. Brown JC, Rosenquist TH, Monaghan DT. ERK2 activation by homocysteine in vascular smooth muscle cells. Biochem Biophys Res Commun 1998;251:669-76.
35. Taha S, Azzi A, Ozer NK. Homocysteine induces DNA synthesis and proliferation of vascular smooth muscle cells by a hydrogen peroxide-independent mechanism. Antioxid Redox Signal 1999;1:365-9.
36. Boscoboinik D, Szewczyk A, Hensey C, Azzi A. Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C. J Biol Chem 1991;266:6188-94.
37. Ozer NK, Palozza P, Boscoboinik D, Azzi A. d-alpha-Tocopherol inhibits low density lipoprotein induced proliferation and protein kinase C activity in vascular smooth muscle cells. FEBS Lett 1993;322:307-10.
38. Boscoboinik D, Ozer NK, Moser U, Azzi A. Tocopherols and 6-hydroxy-chroman-2-carbonitrile derivatives inhibit vascular smooth muscle cell proliferation by a nonantioxidant mechanism. Arch Biochem Biophys 1995;318:241-6.
39. Azzi A. Molecular mechanism of alpha-tocopherol action. Free Radic Biol Med 2007;43:16-21.
40. Brigelius-Flohe R, Kelly FJ, Salonen JT, Neuzil J, Zingg JM, Azzi A. The European perspective on vitamin E: current knowledge and future research. Am J Clin Nutr 2002;76:703-16.
41. Faruqi R, De La Motte C, Di Corleto PE. Alpha-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J Clin Invest 1994;94:592-600.
42. Raghuveer G, Sinkey CA, Chenard C, Stumbo P, Haynes WG. Effect of vitamin E on resistance vessel endothelial dysfunction induced by methionine. Am J Cardiol 2001;88:285-90.
43. Milton N G N. Homocysteine inhibits hydrogen peroxide breakdown by catalase. Open Enzyme Inhibition Journal 2008;1:34-41.
44. Goth L, Vitai M. The effects of hydrogen peroxide promoted by homocysteine and inherited catalase deficiency on human hypocatalasemic patients. Free Radic Biol Med 2003;35:882-8.
45. Lubos E, Loscalzo J, Handy DE. Homocysteine and glutathione peroxidase-1. Antioxid Redox Signal 2007;9:1923-40.
46. Brandes RP, Schroder K. Differential vascular functions of Nox family NADPH oxidases. Curr Opin Lipidol 2008;19:513-8.
47. Violi F, Basili S, Nigro C, Pignatelli P. Role of NADPH oxidase in atherosclerosis. Future Cardiol 2009;5:83-92.
48. Cachia O, Benna JE, Pedruzzi E, Descomps B, Gougerot-Pocidalo MA, Leger CL. alpha-Tocopherol inhibits the respiratory burst in human monocytes. Attenuation of p47 (phox) membrane translocation and phosphorylation. J Biol Chem 1998;273:32801-5.
49. Barnes MJ. Collagens in atherosclerosis. Coll Relat Res 1985;5:65-97.
50. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995;92:1355-74.
51. Jourdheuil-Rahmani D, Rolland PH, Rosset E, Branchereau A, Garcon D. Homocysteine induces synthesis of a serine elastase in arterial smooth muscle cells from multi-organ donors. Cardiovasc Res 1997;34:597-602.
52. Cooke JP, Dzau VJ. Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 1997;48:489-509.
53. Stuhlinger MC, Stanger O. Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst (e) ine and endothelial dysfunction. Curr Drug Metab 2005;6:3-14.
54. Nappo F, De Rosa N, Marfella R, De Lucia D, Ingrosso D, Perna AF, et al. Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA 1999;281:2113-8.
55. Nanayakkara PW, Kiefte-de Jong JC, Ter Wee PM, Stehouwer CD, Van Ittersum FJ, Olthof MR, et al. Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD. Am J Kidney Dis 2009;53:41-50.
56. Barbato JC, Catanescu O, Murray K, Di Bello PM, Jacobsen DW. Targeting of metallothionein by L-homocysteine: a novel mechanism for disruption of zinc and redox homeostasis. Arterioscler Thromb Vasc Biol 2007;27:49-54.
57. Hubmacher D, Cirulis JT, Miao M, Keeley FW, Reinhardt DP. Functional consequences of homocysteinylation of the elastic fiber proteins fibrillin-1 and tropoelastin. J Biol Chem 2010;285:1188-98.
58. Colgan SM, Austin RC. Homocysteinylation of metallothionein impairs intracellular redox homeostasis: the enemy within! Arterioscler Thromb Vasc Biol 2007;27:8-11.
59. Stapelberg M, Gellert N, Swettenham E, Tomasetti M, Witting PK, Procopio A, et al. Alpha-tocopheryl succinate inhibits malignant mesothelioma by disrupting the fibroblast growth factor autocrine loop: mechanism and the role of oxidative stress. J Biol Chem 2005;280:25369-76.
60. Song YL, Ford JW, Gordon D, Shanley CJ. Regulation of lysyl oxidase by interferongamma in rat aortic smooth muscle cells. Arterioscler Thromb Vasc Biol 2000;20:982-8.
61. Liu G, Nellaiappan K, Kagan HM. Irreversible inhibition of lysyl oxidase by homocysteine thiolactone and its selenium and oxygen analogues. Implications for homocystinuria. J Biol Chem 1997;272:32370-7.
62. Lubec B, Fang-Kircher S, Lubec T, Blom HJ, Boers GH. Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim Biophys Acta 1996;1315:159-62.
63. Zulli A, Hare DL. High dietary methionine plus cholesterol stimulates early atherosclerosis and late fibrous cap development which is associated with a decrease in GRP78 positive plaque cells. Int J Exp Pathol 2009;90:311-20.
64. Zulli A, Widdop RE, Hare DL, Buxton BF, Black MJ. High methionine and cholesterol diet abolishes endothelial relaxation. Arterioscler Thromb Vasc Biol 2003;23:1358-63.
65. Esfahani A, Wong JM, Truan J, Villa CR, Mirrahimi A, Srichaikul K, et al. Health effects of mixed fruit and vegetable concentrates: a systematic review of the clinical interventions. J Am Coll Nutr 2011;30:285-94.
66. Can C, Cinar MG, Kosay S, Evinc A. Vascular endothelial dysfunction associated with elevated serum homocysteine levels in rat adjuvant arthritis: effect of vitamin E administration. Life Sci 2002;71:401-10.